MedPath

Effect of Embryo transfers day on infertility treatment

Phase 2
Conditions
Diseases of the genitourinary system.
Noninflammatory disorders of female genital tract
N00-N99
Registration Number
IRCT2014121420306N1
Lead Sponsor
Vice chancellor for research, Shahid Beheshti University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
300
Inclusion Criteria

women aged 20-40 years old undergoing fresh intracytoplasmic sperm injection-embryo transfer cycles; have normal endometrial thickness (7-12 milimeters) on embryo transfers day; don't have any visible endometrial pathology; do not have more than three failed previous intracytoplasmic sperm injection-embryo transfer cycles.
Exclusion criteria: abnormally shaped uterus in hysterosalpingography or hysteroscopy; have more than 3 previous failure of intracytoplasmic sperm injection-embryo transfer cycles .

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy rate. Timepoint: Five weeks after start of intervention. Method of measurement: Transvaginal ultrasonography.;Predicting factors. Timepoint: End of the treatment. Method of measurement: Statistical analysis.
Secondary Outcome Measures
NameTimeMethod
Chemical pregnancy rate. Timepoint: Two weeks after embryo transfer. Method of measurement: Labratory kit.;Ongoing pregnancy rate. Timepoint: 10weeks after embryo transfer. Method of measurement: History, physical exam, ultrasonography.;Miscariage rate. Timepoint: Until 24 weeks after start of intervention. Method of measurement: History, Physical exam, Ultrasonography.;Fertilization rate. Timepoint: After embryo development. Method of measurement: Labratory investigation.;Implantation rate. Timepoint: Two weeks after embryo transfer. Method of measurement: History, Physical exam, Ultrasonography.
© Copyright 2025. All Rights Reserved by MedPath